To investigate the role of the secondary
5-hydroxy group in the
activity of the anticancer drug tigilanol tiglate (
2b
) (Stelfonta), oxidation of this epoxytigliane diterpenoid from the
Australian rainforest plant
Fontainea picrosperma
was attempted. Eventually, 5-dehydrotigilanol tiglate (
3a
) proved too unstable to be characterized in terms of biological
activity and, therefore, was not a suitable tool compound for bioactivity
studies. On the other hand, a series of remarkable skeletal rearrangements
associated with the presence of a 5-keto group were discovered during
its synthesis, including a dismutative ring expansion of ring A and
a mechanistically unprecedented dyotropic substituent swap around
the C-4/C-10 bond. Taken together, these observations highlight the
propensity of the α-hydroxy-β-diketone system to trigger
complex skeletal rearrangements and pave the way to new areas of the
natural products chemical space.